Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used as a stimulant laxative for bowel evacuation.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., colonoscopy, sigmoidoscopy).
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 fl oz (133 mL) enema administered 3-5 hours before the procedure. For larger volumes or repeated doses, follow specific protocol guidelines.
* **Constipation:** One 4.5 fl oz (133 mL) enema administered as a single dose.
## Pediatric Dosing
* **Bowel Preparation & Constipation:** Generally not recommended for children younger than 5 years old. For children 5 years and older, the adult dose (4.5 fl oz or 133 mL) may be used, but caution is advised. **Exact dosing should be determined by a healthcare provider based on the child's age, weight, and clinical condition.** The 2.25 fl oz (67 mL) pediatric size is available and should be used in smaller children as directed.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is warranted in patients with significant electrolyte imbalances or renal disease.
## Contraindications
* Congestive heart failure
* Acute renal failure
* Congenital megacolon
* Intestinal obstruction or perforation
* Anorectal stenosis
* Children younger than 5 years of age
* Patients with impaired defecation mechanisms
* Patients with known or suspected hyperphosphatemia or hypocalcemia
* Patients on medications that may affect renal function or electrolyte balance (e.g., diuretics, ACE inhibitors, ARBs, NSAIDs).
## Adverse Effects
* **Common:** Abdominal discomfort, cramping, nausea, vomiting, bloating, rectal irritation.
* **Serious:** Electrolyte disturbances (hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia), dehydration, cardiac arrhythmias, renal failure, seizures. These are more likely with excessive use, in patients with contraindications, or in susceptible individuals.
## Key Drug Interactions
* **Diuretics, ACE inhibitors, ARBs, NSAIDs:** Increased risk of hyperphosphatemia, hypocalcemia, and acute renal failure due to effects on renal perfusion and tubular function.
* **Drugs affecting electrolyte balance:** Concomitant use can exacerbate electrolyte disturbances.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., thirst, dry mouth, decreased urine output, fatigue, muscle weakness, dizziness, cardiac palpitations).
* Renal function and electrolytes (especially phosphate, calcium, sodium) may be monitored in at-risk patients or with excessive use.
## Clinical Pearls
* Sodium phosphate enemas are a potent osmotic laxative and should be used with caution, strictly adhering to recommended doses and frequencies.
* Excessive use or use in contra-indicated patients can lead to serious and potentially fatal electrolyte imbalances and renal toxicity.
* Ensure adequate hydration before and after administration, especially in children and the elderly.
* Do not use for more than one week unless directed by a healthcare provider.
***
*Disclaimer: This information is intended for healthcare professionals and does not replace current prescribing information. Always consult the official drug monograph and institutional protocols for complete and up-to-date guidance.*
